116 related articles for article (PubMed ID: 8277225)
1. Tumour necrosis factor-alpha modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
J Endocrinol; 1993 Sep; 138(3):517-28. PubMed ID: 8277225
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6.
Jensen BL; Skouv J; Lundholt BK; Lykkesfeldt AE
Br J Cancer; 1999 Feb; 79(3-4):386-92. PubMed ID: 10027303
[TBL] [Abstract][Full Text] [Related]
3. Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and -negative breast carcinomas.
Naundorf H; Parczyk K; Zschiesche W; Reinecke S; Büttner B; Saul GJ; Sinn B; Fichtner I
J Cancer Res Clin Oncol; 1996; 122(1):14-20. PubMed ID: 8543587
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
Hung H
J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
7. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.
Rozen F; Zhang J; Pollak M
Int J Oncol; 1998 Oct; 13(4):865-9. PubMed ID: 9735418
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
James SY; Mackay AG; Binderup L; Colston KW
J Endocrinol; 1994 Jun; 141(3):555-63. PubMed ID: 8071654
[TBL] [Abstract][Full Text] [Related]
11. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ
Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866
[TBL] [Abstract][Full Text] [Related]
12. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.
de Cupis A; Noonan D; Pirani P; Ferrera A; Clerico L; Favoni RE
Br J Pharmacol; 1995 Nov; 116(5):2391-400. PubMed ID: 8581274
[TBL] [Abstract][Full Text] [Related]
13. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
14. Laminin inhibits estrogen action in human breast cancer cells.
Woodward TL; Lu H; Haslam SZ
Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis.
Hawsawi Y; El-Gendy R; Twelves C; Speirs V; Beattie J
Biochim Biophys Acta; 2013 Dec; 1836(2):345-53. PubMed ID: 24189571
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
17. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I.
Thorsen T; Lahooti H; Rasmussen M; Aakvaag A
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):537-40. PubMed ID: 1562524
[TBL] [Abstract][Full Text] [Related]
18. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens.
Clayton SJ; May FE; Westley BR
Mol Cell Endocrinol; 1997 Apr; 128(1-2):57-68. PubMed ID: 9140076
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
